tetraethylammonium has been researched along with Acute Myelogenous Leukemia in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, L | 1 |
| Xu, B | 1 |
| White, RE | 1 |
| Lu, L | 1 |
1 other study available for tetraethylammonium and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Growth factor-mediated K+ channel activity associated with human myeloblastic ML-1 cell proliferation.
Topics: 4-Aminopyridine; Animals; Barium Compounds; Blood; Cattle; Cell Cycle; Cell Division; Chlorides; Cul | 1997 |